Ute Hoch
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer-related Molecular Pathways
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 46
- Cancer Immunotherapy and Biomarkers 18
- Cancer Treatment and Pharmacology 13
- CAR-T cell therapy research 8
-
- Enzyme Catalysis and Immobilization 11
- Cancer therapeutics and mechanisms 11
- Co-authors
- Paul R. Ortiz de Montellano (5 shared papers)Peter Schreier (14 shared papers)Chantu R. Saha‐Möller (9 shared papers)Waldemar Adam (12 shared papers)Michael A. Eldon (8 shared papers)Judith A. Fox (5 shared papers)Jonathan Zalevsky (17 shared papers)Mary Tagliaferri (20 shared papers)
- Journals
- Journal of Clinical Oncology (17 papers)Cancer Research (8 papers)Cancer Chemotherapy and Pharmacology (7 papers)Journal of Biological Chemistry (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)
- Partner nations
- United StatesBelgiumUnited Kingdom
In The Last Decade
Ute Hoch
86 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 103
- Oncology 832
- Pharmacology 224
- Biochemistry 115
- Immunology 294
- Molecular Biology 771
Countries citing papers authored by Ute Hoch
This map shows the geographic impact of Ute Hoch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Hoch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Hoch more than expected).
Fields of papers citing papers by Ute Hoch
This network shows the impact of papers produced by Ute Hoch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Hoch. The network helps show where Ute Hoch may publish in the future.
Co-authors
The 25 scholars most cited alongside Ute Hoch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 176 | |
| 2 | 2010 | 174 | |
| 3 | 2017 | 113 | |
| 4 | 2009 | 107 | |
| 5 | 1999 | 103 | |
| 6 | 2000 | 77 | |
| 7 | 2012 | 74 | |
| 8 | 2001 | 64 | |
| 9 | 2004 | 62 | |
| 10 | 2015 | 62 | |
| 11 | 2009 | 53 | |
| 12 | 2008 | 52 | |
| 13 | 2013 | 49 | |
| 14 | 1995 | 49 | |
| 15 | 2014 | 45 | |
| 16 | 1993 | 45 | |
| 17 | 2012 | 43 | |
| 18 | 2002 | 43 | |
| 19 | 2010 | 42 | |
| 20 | 2004 | 41 |
About Ute Hoch
Ute Hoch is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Pharmacology, having authored 86 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (18 papers), Cancer Treatment and Pharmacology (13 papers), Pharmacogenetics and Drug Metabolism (11 papers), Enzyme Catalysis and Immobilization (11 papers), Cancer therapeutics and mechanisms (11 papers), Immune Cell Function and Interaction (10 papers), Immunotherapy and Immune Responses (8 papers) and CAR-T cell therapy research (8 papers). The work is most often cited by research in Oncology (832 citations), Pharmacology (224 citations), Biochemistry (115 citations), Immunology (294 citations) and Molecular Biology (771 citations). Ute Hoch has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Paul R. Ortiz de Montellano, Peter Schreier, Chantu R. Saha‐Möller, Waldemar Adam, Michael A. Eldon, Judith A. Fox, Jonathan Zalevsky, Mary Tagliaferri, Michael Lazarus and Jeffrey A. Silverman. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Cancer Chemotherapy and Pharmacology, Journal of Biological Chemistry and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.